{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:34:56Z","timestamp":1790861696867,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1006\/exnr.1998.6906","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:46:56Z","timestamp":1032191216000},"page":"214-222","source":"Crossref","is-referenced-by-count":24,"title":["Chronic Exposure to MPTP as a Primate Model of Progressive Parkinsonism: A Pilot Study with a Free Radical Scavenger"],"prefix":"10.1006","volume":"153","author":[{"given":"P.J.","family":"Blanchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Konitsiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.D.","family":"Pettigrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.N.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1998.6906_EN986906RF1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0006-2952(91)90646-M","article-title":"Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain","volume":"41","author":"Adams","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0306-4522(93)90444-K","article-title":"Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates","volume":"55","author":"Albanese","year":"1993","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/syn.890180105","article-title":"MPTP-induced oxidative stress and neurotoxicity are age-dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels","volume":"18","author":"Ali","year":"1994","journal-title":"Synapse"},{"key":"10.1006\/exnr.1998.6906_EN986906RF4","first-page":"25","article-title":"Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease","volume":"12","author":"Anglade","year":"1997","journal-title":"Histol. Histopathol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/exnr.1998.6906_EN986906RF6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02251137","article-title":"Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates","volume":"3","author":"Bodis-Wollner","year":"1991","journal-title":"J. Neural Transm."},{"key":"10.1006\/exnr.1998.6906_EN986906RF7","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra byN","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1998.6906_EN986906RF8","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM198505303122203","article-title":"The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"312","author":"Burns","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.1998.6906_EN986906RF9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1471-4159.1991.tb02134.x","article-title":"Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain","volume":"57","author":"Chan","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.6906_EN986906RF10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1972.00490180022006","article-title":"Central monoamine metabolism in Parkinson's disease","volume":"27","author":"Chase","year":"1972","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF11","series-title":"Parkinson's Disease","article-title":"Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease","volume":"69","author":"Chase","year":"1996"},{"key":"10.1006\/exnr.1998.6906_EN986906RF12","first-page":"1252","article-title":"Estrogen may protect females from Parkinson's disease","volume":"21","author":"Chen","year":"1995","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1006\/exnr.1998.6906_EN986906RF13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1994.tb21786.x","article-title":"In vivo","volume":"738","author":"Chiueh","year":"1994","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1006\/exnr.1998.6906_EN986906RF14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0140-6736(87)90260-1","article-title":"Timing of levodopa therapy: Evidence from MPTP-treated primates","volume":"1","author":"Clarke","year":"1987","journal-title":"Lancet"},{"key":"10.1006\/exnr.1998.6906_EN986906RF15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(84)90700-3","article-title":"Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys","volume":"106","author":"Cohen","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1471-4159.1996.66020658.x","article-title":"Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release","volume":"66","author":"Dluzen","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.6906_EN986906RF17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(86)90102-8","article-title":"Variability and functional recovery in theN","volume":"18","author":"Eidelberg","year":"1986","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0022-510X(91)90169-8","article-title":"Total biopterin levels in the ventricular CSF of patients with Parkinson's disease: A comparison between akineto-rigid and tremor types","volume":"103","author":"Furukawa","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/exnr.1998.6906_EN986906RF19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0922-4106(91)90073-Q","article-title":"MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease","volume":"208","author":"Gerlach","year":"1991","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol. Sect."},{"key":"10.1006\/exnr.1998.6906_EN986906RF20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-4522(88)90320-X","article-title":"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost","volume":"24","author":"German","year":"1988","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-4886(92)90125-A","article-title":"Effect of chronic treatment with (+)-PHNO, a D2","volume":"117","author":"Gomez-Mancilla","year":"1992","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mds.870080205","article-title":"Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors","volume":"8","author":"Gomez-Mancilla","year":"1993","journal-title":"Movement Dis."},{"key":"10.1006\/exnr.1998.6906_EN986906RF23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(93)90295-Q","article-title":"Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons","volume":"53","author":"Hantraye","year":"1993","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(96)12323-5","article-title":"Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice","volume":"204","author":"Hassouna","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1998.6906_EN986906RF25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-4522(91)90180-V","article-title":"Selective retention of MPP+","volume":"40","author":"Herkenham","year":"1991","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0378-4347(00)83594-X","article-title":"Estimation of tetrahydrobiopterin and other pterins in cerebrospinal fluid using reversed phase high performance liquid chromatography with electrochemical and fluorescence detection","volume":"381","author":"Howells","year":"1986","journal-title":"J. Chromatogr."},{"key":"10.1006\/exnr.1998.6906_EN986906RF27","first-page":"1654","article-title":"A new chronic MPTP model: Validation in monkey and mouse","volume":"23","author":"Imbert","year":"1997","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1006\/exnr.1998.6906_EN986906RF28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0006-8993(90)90780-F","article-title":"The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey","volume":"532","author":"Irwin","year":"1990","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6906_EN986906RF29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-8993(92)90473-M","article-title":"The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL\/6 mice: A critical reassessment","volume":"572","author":"Irwin","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6906_EN986906RF30","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF31","first-page":"285","article-title":"A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+","volume":"12","author":"Johannessen","year":"1991","journal-title":"NeuroToxicology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1006\/exnr.1998.6906_EN986906RF33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.1998.6906_EN986906RF34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0306-4522(86)90079-5","article-title":"Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hydroxylase immunocytochemical study in monkey","volume":"17","author":"Kitt","year":"1986","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF35","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1212\/WNL.47.6_Suppl_3.153S","article-title":"The etiology of Parkinson's disease with emphasis on the MPTP story","volume":"47","author":"Langston","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF36","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","article-title":"The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease","volume":"47","author":"Leenders","year":"1990","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1126\/science.6117945","article-title":"Tetrahydrobiopterin in striatum: Localization in dopamine nerve terminals and role in catecholamine synthesis","volume":"214","author":"Levine","year":"1981","journal-title":"Science"},{"key":"10.1006\/exnr.1998.6906_EN986906RF38","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1212\/WNL.42.11.2111","article-title":"Markers of dopamine metabolism in Parkinson's disease","volume":"42","author":"LeWitt","year":"1992","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF39","first-page":"A408","article-title":"Monoaminergic metabolism, substance P, met-enkephalin, and biopterin in Parkinson's disease","volume":"43","author":"LeWitt","year":"1993","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.432666","article-title":"Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease","volume":"204","author":"Lovenberg","year":"1979","journal-title":"Science"},{"key":"10.1006\/exnr.1998.6906_EN986906RF41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(94)90194-5","article-title":"Functional interaction between dopamine D12","volume":"253","author":"Luquin","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF42","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/clinchem\/30.9.1477","article-title":"n","volume":"30","author":"Matson","year":"1984","journal-title":"Clin. Chem."},{"key":"10.1006\/exnr.1998.6906_EN986906RF43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02251138","article-title":"Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: Preliminary observations","volume":"3","author":"Mihatsch","year":"1991","journal-title":"J. Neural Transm."},{"key":"10.1006\/exnr.1998.6906_EN986906RF44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3940(94)90271-2","article-title":"Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+","volume":"170","author":"Mochizuki","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1998.6906_EN986906RF45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0022-510X(95)00336-Z","article-title":"Histochemical detection of apoptosis in Parkinson's disease","volume":"137","author":"Mochizuki","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/exnr.1998.6906_EN986906RF46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0009-8981(81)90316-8","article-title":"Biopterin in human brain and urine from controls and parkinsonian patients: Application of a new radioimmunoassay","volume":"109","author":"Nagatsu","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1006\/exnr.1998.6906_EN986906RF47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0197-4580(95)02012-8","article-title":"Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys","volume":"16","author":"Ovadia","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1006\/exnr.1998.6906_EN986906RF48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","volume":"328","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.1998.6906_EN986906RF49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archneur.1995.00540270025015","volume":"52","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ana.410400116","volume":"40","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(85)90229-0","article-title":"Partial protection from the dopaminergic neurotoxinN","volume":"60","author":"Perry","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1998.6906_EN986906RF52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0306-4522(91)90080-8","article-title":"Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey","volume":"44","author":"Pifl","year":"1991","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1471-4159.1990.tb08853.x","article-title":"Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures","volume":"55","author":"Reinhard","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.6906_EN986906RF54","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/0006-2952(89)90572-8","article-title":"Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets","volume":"38","author":"Rose","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(91)90171-O","article-title":"Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease","volume":"123","author":"Russ","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1998.6906_EN986906RF56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410260409","article-title":"Striatal dopamine deficiency in Parkinson's disease: Role of aging","volume":"26","author":"Scherman","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(90)90069-N","article-title":"Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys","volume":"519","author":"Schneider","year":"1990","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6906_EN986906RF58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-4886(95)90033-0","article-title":"Coenzyme Q10","volume":"132","author":"Schulz","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF59","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0028-3908(85)90163-7","article-title":"Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid","volume":"24","author":"Sershen","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.40.2.261","article-title":"Cognitive change following MPTP exposure","volume":"40","author":"Stern","year":"1990","journal-title":"Neurology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF61","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF62","series-title":"Neurodegeneration and Neuroprotection in Parkinson's Disease","first-page":"209","article-title":"Reduction of neuronal apoptosis by small molecules: promise for new approaches to neurological therapy","author":"Tatton","year":"1996"},{"key":"10.1006\/exnr.1998.6906_EN986906RF63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02260911","article-title":"Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: Relationship to clinical symptoms and subsequent therapeutic outcomes","volume":"5","author":"Tohgi","year":"1993","journal-title":"J. Neural Transm."},{"key":"10.1006\/exnr.1998.6906_EN986906RF64","doi-asserted-by":"crossref","first-page":"144P","DOI":"10.1016\/S0021-5198(19)46540-2","article-title":"Protective effects of OPC-14117 on dopaminergic neuronal degeneration induced by MPTP in ICR mice","volume":"67","author":"Tottori","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000116308","article-title":"Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease","volume":"26","author":"Turkka","year":"1987","journal-title":"Eur. Neurol."},{"key":"10.1006\/exnr.1998.6906_EN986906RF66","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0028-3908(89)90122-6","article-title":"Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin","volume":"28","author":"Ueki","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1006\/exnr.1998.6906_EN986906RF67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0306-4522(94)90006-X","article-title":"Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease","volume":"63","author":"Varastet","year":"1994","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6906_EN986906RF68","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.1992.tb09429.x","article-title":"MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates","volume":"59","author":"Zuddas","year":"1992","journal-title":"J. Neurochem."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488698969060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488698969060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T03:50:03Z","timestamp":1620013803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488698969060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["S0014488698969060"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1998.6906","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}